https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/13/issue/2
Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
APSB is a monthly journal, in English, which publishes significant original research articles, rapid communications and high-quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
Articles of interest in this issue include:
Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism by Changpei Gan, Jing Wang, Alejandra Martínez-Chávez et al. (https://doi.org/10.1016/j.apsb.2022.10.017). Carboxylesterase 1 enzymes impact in vivo pharmacokinetics of anticancer prodrugs irinotecan and capecitabine. Lipid homeostasis in adipose tissues is also regulated by CES1, partly through triglyceride mobilization in liver.
A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis by Dan Wang, Bochuan Deng, Lu Cheng et al. (https://doi.org/10.1016/j.apsb.2022.09.001). Novel peptide DR3penA with high stability and low toxicity effectively attenuates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis.
Other articles include:
Review Articles
Expression and functions of transient receptor potential channels in liver diseases
Wenhui Wang, Pengyu Liu, Yalin Zhang, Li Yan, … Ye Yu
Zhengjie Lu, Yu Guo, Dan Xu, Hao Xiao, … Hui Wang
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Chen Fu, Lifeng Yu, Yuxi Miao, Xinli Liu, … Minjie Wei
Medical micro- and nanomotors in the body
Huaan Li, Fei Peng, Xiaohui Yan, Chun Mao, … Yingfeng Tu
Original Articles
Nazi Song, Hongjiao Xu, Shuohan Wu, Suijia Luo, … Xianxing Jiang
Yujun Zhou, Jingshu Tang, Jiaqi Lan, Yong Zhang, … Ying Peng
Yin Feng, Yefan Han, Anni Hu, Yi Qu, … Li He
Jizhou Tan, Ting Liu, Wenzhe Fan, Jialiang Wei, … Jiaping Li
Jian Lu, Xuyang Shang, Bingyi Yao, Dongyi Sun, … Xin Wang
Yang Liu, Ting Liu, Yuanzhang Zhou, Wenjie Li, … Ming Lu
Haowen Xu, Jiahao Chen, Pan Chen, Weifeng Li, … Guang Liang
Di Zhao, Jing Zhang, Lingyuan Zhang, Qingnan Wu, … Qimin Zhan
Siyuan Tang, Miguel Garzon Sanz, Oliver Smith, Andreas Krämer, … Sam Butterworth
Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia
Zhifu Xie, Mei Zhang, Qian Song, Long Cheng, … Fajun Nan
Lingyan Wang, Guiyang Xia, Huan Xia, Xiaohong Wei, … Sheng Lin
Meng Chen, Zhengyan Guo, Jinyuan Sun, Wei Tang, … Yihua Chen
Qianhua Feng, Yutong Hao, Shuaiqi Yang, Xiaomin Yuan, … Lei Wang
Yijun Chen, Kaiming Li, Mengying Jiao, Yingshuang Huang, … Can Zhang
Tao He, Mingxing Hu, Shunyao Zhu, Meiling Shen, … Changyang Gong
Ze Mi, Qing Yao, Yan Qi, Jinhai Zheng, … Pengfei Rong
Dayuan Wang, Xiao Gu, Xinyi Ma, Jun Chen, … Hongzhuan Chen
Xiaolin Zhang, Xueyan Zhen, Yixuan Yang, Quan Feng, … Xiaoyu Xie
Lujing Geng, Tong Lu, Huaqing Jing, Yue Zhou, … Nan Li
Jianjun Cheng, Haitian Zhao, Bin Li, Hua Zhang, … Xin Yang